Comparison of antihypertensive drug utilization in community health centre and type B teaching hospital

Authors

  • Tromphin Sitorus Faculty of Medicine, Universitas Kristen Indonesia, Jakarta
  • Abraham Simatupang Department of Pharmacology and Therapy – Faculty of Medicine, Universitas Kristen Indonesia https://orcid.org/0000-0003-2497-9738

DOI:

https://doi.org/10.32734/idjpcr.v6i1.11982

Abstract

Antihypertensive medicine is one of the many complex factors contributing to the sustained rise in hypertension prevalence, which remains a global health concern. The Social Security Agency on Health, or Badan Penyelenggara Jaminan Social (BPJS) Kesehatan, in Indonesia is an integrated healthcare system that provides universal healthcare to its citizens. This retrospective cross-sectional study examined the use of antihypertensive medications covered by BPJS between January and December 2021 at the Rawabuntu Primary Health Centre and the Universitas Kristen Indonesia (UKI) type B public hospital. The necessary data was extracted from the medical files of 192 hypertensive patients. The patients' characteristics were analysed descriptively. The rationality of antihypertensive medication use was evaluated in accordance with Association of Indonesian Hypertension Physicians-approved guidelines. The majority of patients in both categories were female (52.1 percent at the Rawabuntu Primary Health Centre and 60 percent at the teaching facility). In both healthcare facilities, the correct indication, patient, and dosage were administered 100 percent of the time, according to this study. While only 66.7% and 85.4% of patients at the Rawabuntu Primary Health Centre and UKI hospital received the correct drug category, respectively. The rational use of antihypertensive medications was substantially lower at the Primary Health Centre than it was at the UKI Hospital (p = 0.001).

Downloads

Download data is not yet available.

References

Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334–57. doi: 10.1161/HYPERTENSIONAHA.120.15026.

Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cífková R, Dominiczak AF, et al. Hypertension. Nat Rev Dis Prim. 2018 Mar;4:18014. https://doi.org/10.1038/nrdp.2018.14.

Kemenkes RI. Hasil Riset Kesehatan Dasar Tahun 2018. Vol. 53. 2018.

Kim IG, So WY, Sung DJ. The relationships between lifestyle factors and hypertension in community-dwelling Korean adults. J Phys Ther Sci 2015;27(12):3689–3692. doi: 10.1589/jpts.27.3689.

Bruno CM, Amaradio MD, Pricoco G, Marino E, Bruno F. Lifestyle and Hypertension: An Evidence-Based Review. J Hypertens Manag. 2018;4(1):1–10. doi.org/10.23937/2474-3690/1510030.

BPJS Kesehatan. Panduan Layanan Bagi Peserta Jaminan Kesehatan Nasional Kartu Indonesia Sehat (JKN-KIS). 2021.

Perhimpunan Dokter Hipertensi Indonesia (PERHI). Konsensus Penatalaksanaan Hipertensi 2019. Indones Soc Hipertens Indones. 2019;1– 90.

Lemauk P. Gambaran Penderita Hipertensi di Rumah Sakit Umum Universitas Kristen Indonesia Tahun 2020. [Jakarta]: Universitas Kristen Indonesia; 2022.

Harvey A, Montezano AC, Touyz RM. Vascular biology of ageing— Implications in hypertension. J Mol Cell Cardiol. 2015;83:112–21. doi: 10.1016/j.yjmcc.2015.04.011.

Marinier K, Macouillard P, de Champvallins M, Deltour N, Poulter N, Mancia G. Effectiveness of two‐drug therapy versus monotherapy as initial regimen in hypertension: A propensity score‐matched cohort study in the UK Clinical Practice Research Datalink. Pharmacoepidemiol Drug Saf. 2019;28(12):1572–82. doi: 10.1002/pds.4884.

Salam A, Kanukula R, Atkins E, Wang X, Islam S, Kishore SP, et al. Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: a systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2019;37(9):1768–74. doi: 10.1097/HJH.0000000000002096.

Hendarti Hana F, Siddiqa A, Sari FR. Evaluasi Ketepatan Obat dan Dosis Obat Antihipertensi pada Pasien Hipertensi Rawat Jalan di Puskesmas Ciputat Januari-Maret 2015. [Tangerang Selatan]: UIN Jakarta; 2016.

Alaydrus S, Toding N. Pola Penggunaan Obat Hipertensi Pada Pasien Geriatri Di Rumah Sakit Anutapura Palu Periode 08 Juli-08 Agustus 2019. Jurnal Mandala Pharmacon Indonesia. 2019;5(02):65–73. doi: https://doi.org/10.35311/jmpi.v5i02.46.

Widiyanti Y. Evaluasi Penggunaan Obat Antihipertensi Di Puskesmas Leuwigajah Kota Cimahi. 2018.

Triyadi R, Rokiban A, Carima A. Evaluasi Penggunaan Obat Pada Pasien Hipertensi Rawat Jalan Di Rumah Sakit Umum Wisma Rini Pringsewu Tahun 2019. JFL: Jurnal Farmasi Lampung. 2021;9(2):84–91. doi: 10.37090/jfl.v9i2.336.

Published

2023-07-07

How to Cite

Sitorus , T. ., & Simatupang, A. . (2023). Comparison of antihypertensive drug utilization in community health centre and type B teaching hospital . Indonesian Journal of Pharmaceutical and Clinical Research, 6(1), 25-30. https://doi.org/10.32734/idjpcr.v6i1.11982